ATE269676T1 - Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen - Google Patents

Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen

Info

Publication number
ATE269676T1
ATE269676T1 AT99911462T AT99911462T ATE269676T1 AT E269676 T1 ATE269676 T1 AT E269676T1 AT 99911462 T AT99911462 T AT 99911462T AT 99911462 T AT99911462 T AT 99911462T AT E269676 T1 ATE269676 T1 AT E269676T1
Authority
AT
Austria
Prior art keywords
controlled release
bioactive substances
polymer solution
liquid polymer
glycolide
Prior art date
Application number
AT99911462T
Other languages
English (en)
Inventor
Rey T Chern
Joel R Zingerman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9815801.7A external-priority patent/GB9815801D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE269676T1 publication Critical patent/ATE269676T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT99911462T 1998-03-19 1999-03-18 Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen ATE269676T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7957498P 1998-03-19 1998-03-19
GBGB9815801.7A GB9815801D0 (en) 1998-07-21 1998-07-21 Liquid polymeric compositions for controlled released bioactive substances
PCT/US1999/005938 WO1999047073A1 (en) 1998-03-19 1999-03-18 Liquid polymeric compositions for controlled release of bioactive substances

Publications (1)

Publication Number Publication Date
ATE269676T1 true ATE269676T1 (de) 2004-07-15

Family

ID=26314072

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99911462T ATE269676T1 (de) 1998-03-19 1999-03-18 Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen

Country Status (29)

Country Link
EP (2) EP1063942B1 (de)
KR (1) KR100684055B1 (de)
CN (1) CN1263435C (de)
AT (1) ATE269676T1 (de)
AU (1) AU745841B2 (de)
BG (1) BG64782B1 (de)
BR (1) BRPI9908893B8 (de)
CA (1) CA2324265C (de)
CY (1) CY1111669T1 (de)
CZ (1) CZ300822B6 (de)
DE (1) DE69918275T2 (de)
DK (1) DK1063942T3 (de)
EA (1) EA003460B1 (de)
EE (1) EE04216B1 (de)
ES (1) ES2222694T3 (de)
HR (1) HRP20000618B1 (de)
HU (1) HU226711B1 (de)
ID (1) ID25808A (de)
IL (2) IL137982A0 (de)
IS (1) IS2221B (de)
ME (1) ME00867B (de)
NO (1) NO329589B1 (de)
NZ (1) NZ506415A (de)
PL (1) PL192270B1 (de)
PT (1) PT1063942E (de)
SI (1) SI1063942T1 (de)
SK (1) SK286612B6 (de)
TR (1) TR200002685T2 (de)
WO (1) WO1999047073A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033603B2 (en) * 1999-08-06 2006-04-25 Board Of Regents The University Of Texas Drug releasing biodegradable fiber for delivery of therapeutics
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
NZ523385A (en) * 2000-06-28 2005-09-30 Atul J Biodegradable vehicles and BAS-loaded delivery systems for use as biodegradable fillers and/or spacers, e.g. artificial skin
HK1052310B (en) * 2000-09-01 2011-12-16 Palmaya Pty Ltd. Slow release pharmaceutical preparation and method of administering same
ATE427760T1 (de) 2001-02-23 2009-04-15 Genentech Inc Erodierbare polymere zur injektion
JP5170935B2 (ja) * 2001-11-14 2013-03-27 デュレクト コーポレーション 注入可能なデポー組成物
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
WO2004103342A2 (en) * 2003-05-16 2004-12-02 Alkermes Controlled Therapeutics, Inc. Injectable sustained release compositions
CN1293921C (zh) * 2003-08-18 2007-01-10 王玉万 含乙基纤维素和脂肪酸酯类的长效注射剂
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
TWI369218B (en) * 2004-12-14 2012-08-01 Novartis Ag In situ forming implant for animals
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
TW200924647A (en) * 2007-08-30 2009-06-16 Schering Plough Ltd Local topical administration formulations containing fipronil
BRPI0705822A2 (pt) * 2007-10-25 2009-06-23 Schering Plough Saude Animal Ltda formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável
US20090181068A1 (en) 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
US20090281150A1 (en) * 2008-04-09 2009-11-12 Nicola Frances Bateman Compound 249
BRPI0802255A2 (pt) * 2008-06-17 2010-03-16 Sespo Ind E Com Ltda composição de uso tópico para controle de ectoparasitos em cães e gatos
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US12171463B2 (en) 2008-10-03 2024-12-24 Femasys Inc. Contrast agent generation and injection system for sonographic imaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
WO2010106325A2 (en) 2009-03-18 2010-09-23 Omnipharm Limited Parasiticidal formulation
DE102011114986A1 (de) * 2011-09-28 2013-03-28 Ethris Gmbh Sprühsystem
EP3079668A1 (de) 2013-12-09 2016-10-19 Durect Corporation Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
US8785426B1 (en) 2013-12-13 2014-07-22 Upsher-Smith Laboratories, Inc. Testosterone gel compositions and related methods
CN107811967B (zh) * 2016-09-09 2021-08-24 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) 抗寄生虫药物原位固化缓释注射剂及其制备方法
WO2019050259A1 (ko) * 2017-09-06 2019-03-14 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
KR102101969B1 (ko) 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
CN111675778B (zh) * 2020-06-15 2021-11-02 苏州大学 基于pisa方法制备的偶氮还原酶响应性的近红外聚合物荧光探针及其应用
EP4208157A1 (de) 2020-09-04 2023-07-12 Elanco Us Inc. Wohlschmeckende formulierungen
EP4001288B1 (de) 2020-11-19 2025-05-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Verfahren zur herstellung von tenbolonacetat mit einer bestimmten partikelgrössenverteilung und einem kristallhabitus mit unregelmässigen sechseckplatten
EP4001289B1 (de) 2020-11-19 2023-05-03 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Verbessertes verfahren zur herstellung von trenbolon und/oder trenbolonacetat
EP4000688B1 (de) 2020-11-19 2025-11-05 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Verfahren zur herstellung von tenbolonacetat mit bestimmter partikelgrössenverteilung
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150108A (en) * 1975-12-29 1979-04-17 Graham Neil B Injectable medicinal compositions
DE2965725D1 (en) * 1978-07-19 1983-07-28 Patrick Couvreur Biodegradable nanoparticles, pharmaceutical compositions containing them and process for their preparation
US4489055A (en) * 1978-07-19 1984-12-18 N.V. Sopar S.A. Process for preparing biodegradable submicroscopic particles containing a biologically active substance and their use
US4331652A (en) * 1979-09-12 1982-05-25 Eli Lilly And Company Controlled release parasitic formulations and method
US4333919A (en) * 1979-09-12 1982-06-08 Eli Lilly And Company Growth promotant controlled release formulations and method of treatment
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
EP0092918B1 (de) * 1982-04-22 1988-10-19 Imperial Chemical Industries Plc Mittel mit verzögerter Freigabe
DE3400106A1 (de) * 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
EP0670717B1 (de) * 1992-11-30 1998-11-25 Pfizer Inc. Verabreichungsvorrichtungen mit gestützten flüssigen membranen

Also Published As

Publication number Publication date
CY1111669T1 (el) 2015-10-07
NO329589B1 (no) 2010-11-15
EE04216B1 (et) 2004-02-16
CZ300822B6 (cs) 2009-08-19
HRP20000618B1 (en) 2010-10-31
HK1036579A1 (zh) 2002-01-11
AU3010099A (en) 1999-10-11
ID25808A (id) 2000-11-09
HUP0102385A2 (hu) 2002-03-28
EP1063942A1 (de) 2001-01-03
SK286612B6 (sk) 2009-02-05
BRPI9908893B8 (pt) 2021-05-25
BR9908893A (pt) 2000-11-28
EE200000539A (et) 2002-02-15
CN1293553A (zh) 2001-05-02
NZ506415A (en) 2003-06-30
IS2221B (is) 2007-03-15
CA2324265A1 (en) 1999-09-23
EP1484033A1 (de) 2004-12-08
IS5599A (is) 2000-08-22
EP1484033B1 (de) 2011-02-23
AU745841B2 (en) 2002-04-11
BR9908893B1 (pt) 2013-11-19
SI1063942T1 (en) 2004-10-31
TR200002685T2 (tr) 2000-12-21
CA2324265C (en) 2008-08-05
ES2222694T3 (es) 2005-02-01
BG104838A (en) 2001-07-31
EA200000964A1 (ru) 2001-02-26
NO20004616D0 (no) 2000-09-15
HK1031990A1 (en) 2001-07-06
BG64782B1 (bg) 2006-04-28
DE69918275T2 (de) 2005-07-07
KR100684055B1 (ko) 2007-02-16
IL137982A0 (en) 2001-10-31
HUP0102385A3 (en) 2002-12-28
DE69918275D1 (de) 2004-07-29
EA003460B1 (ru) 2003-06-26
CN1263435C (zh) 2006-07-12
KR20010041987A (ko) 2001-05-25
SK13752000A3 (sk) 2001-03-12
HU226711B1 (en) 2009-07-28
HRP20000618A2 (en) 2001-08-31
DK1063942T3 (da) 2005-11-07
PL192270B1 (pl) 2006-09-29
WO1999047073A1 (en) 1999-09-23
EP1063942A4 (de) 2002-07-10
ME00867B (me) 2008-08-07
PL342858A1 (en) 2001-07-16
EP1063942B1 (de) 2004-06-23
IL137982A (en) 2006-10-05
NO20004616L (no) 2000-09-15
CZ20003420A3 (en) 2001-05-16
PT1063942E (pt) 2004-10-29

Similar Documents

Publication Publication Date Title
ATE269676T1 (de) Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen
DE69914787D1 (de) Flüssige zusammensetzungen mit kontrollierter freigabe mit niedrigem initialfreisetzungsstoss des wirkstoffs
DK0752245T3 (da) Biokompatible og bionedbrydelige nanopartikler udviklet til absorption og afgivelse af proteinholdige lægemidler
DK561588A (da) Implanterbart biologisk nedbrydeligt system til frigivelse af biologisk virksomme stoffer
DE69534780D1 (de) Flüssige Zusammensetzungen zur Arzneistoffabgabe
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
ZA914517B (en) Process for coating active principles with a ph-sensitive polymer
YU54100A (sh) Tečne polimerne smeše za kontrolisano oslobadjanje bioaktivnih supstanci
ES2073454T3 (es) Soporte para moleculas biologicamente activas o a su vez biologicamente activo, su procedimiento de preparacion y su aplicacion en biologia.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1063942

Country of ref document: EP

EEFA Change of the company name